🇺🇸 FDA
Pipeline program

P3C541b Lipopeptide

090

Phase 1 mab completed

Quick answer

P3C541b Lipopeptide for HIV Infections is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
HIV Infections
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials